REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Merakipharma Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Merakipharma Cia.Ltda Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Merakipharma Cia.Ltda is based in Ecuador, with the head office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on May 02, 2019. The total number of employees is currently 2 (2023). The latest financial highlights indicate a net sales revenue drop of 80.06% in 2023. Its’ total assets recorded a growth of 0.24%. The enterprise’s net profit margin increased by 7.61% in 2023.

Headquarters
Pedro Menendez Gilbert 2002
Quito; Pichincha;

Contact Details: Purchase the Merakipharma Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Merakipharma Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Merakipharma Cia.Ltda report to view the information.
Registered Capital:
Purchase the Merakipharma Cia.Ltda report to view the information.
Incorporation Date:
May 02, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Merakipharma Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-80.06%▼
Total operating revenue
-80.06%▼
Operating profit (EBIT)
-58.41%▼
Net Profit (Loss) for the Period
0.74%▲
Total assets
0.24%▲
Total equity
8.1%▲
Operating Profit Margin (ROS)
5.63%▲
Net Profit Margin
7.61%▲
Return on Equity (ROE)
-0.55%▼
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo